ICU vs MDAI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 03, 2026
ICU
MDAI
Investment Advisor Scores
MDAI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ICU | MDAI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 52.356 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 82.0% | -30.4% | ICU |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 31.7/100 | 46.9/100 | MDAI |
| Profit Margin | 0.0% | -65.5% | ICU |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | BUY | MDAI |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ICU
NeutralMixed signals - no dominant trend phase, RSI 77
MDAI
NeutralMixed signals - no dominant trend phase, RSI 56
Fundamentals Snapshot
| Metric | ICU | MDAI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -2.0 | -5.4 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.8% | -0.3% |
| Gross Margin | 0.9% | 0.4% |
| Operating Margin | -6.2% | -1.2% |
| EPS | -1.89 | -0.32 |
| Dividend Yield | — | — |